(DTIL)
0.00
0.00 (0.00%)

0.00
0.00 (0.00%)
Precision BioSciences, Inc., klinik bosqichdagi gen tahrirlash kompaniyasi, Qo'shma Shtatlarda genlarni qo'shish, chiqarib tashlash va yo'q qilishni o'z ichiga olgan gen tahrirlari uchun in vivo gen tahrirlash terapiyasini ishlab chiqadi. Kompaniya DNK genomini qo'shish, olib tashlash va ta'mirlash uchun genom tahrirlash platformasi ARCUSni taklif etadi. Shuningdek, u surunkali gepatit B virusi (HBV) ni davolash uchun PBGENE-HBVni to'g'ridan-to'g'ri kesish va tahrirlash orqali kovalent yopiq doira DNKsini yo'q qilish, shuningdek, uzoq muddatli gepatit B sirt antigenni kamaytirish maqsadida integratsiyalashgan HBV DNKsini inaktivatsiya qilish uchun; va Duchenne mushak distrofiyasini davolash uchun PBGENE-DMD (Excision)ni taqdim etadi. Bundan tashqari, kompaniya m.3243 bilan bog'liq mitoxondrial kasalliklarni davolash uchun PBGENE-3243ni; va ornitin transkarbamilaza etishmovchiligi uchun iECURE-OTC (Insertion)ni ishlab chiqadi. U TG Cell Therapy, Inc. bilan autoimmün kasalliklar va boshqa ko'rsatmalarni ishlab chiqish, ishlab chiqarish va tijoratlashtirish uchun; va iECURE, Inc. bilan ARCUS orqali maqsadli gen qo'shish bo'yicha hamkorlik shartnomalariga ega. Precision BioSciences, Inc. 2006-yilda tashkil etilgan va Shimoliy Karolina shtatining Dyurhem shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Cassie Gorsuch Ph.D. | Chief Scientific Officer |
| Dr. Jefferson J. Smith Ph.D. | Co-Founder & Chief Research Officer |
| Mr. Dario Scimeca J.D. | General Counsel & Secretary |
| Mr. John Alexander Kelly R.Ph. | CFO & Principal Accounting Officer |
| Mr. Michael Amoroso | President, CEO & Director |
| Mr. Naresh Tanna | Chief of Staff to CEO & Head of Investor Relations |
| Mr. Neil Leatherbury M.S. | Senior VP and Head of Chemistry, Manufacturing & Controls |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-17 | 8-K | dtil-20260317.htm |
| 2026-03-12 | 8-K | dtil-20260312.htm |
| 2026-01-13 | 8-K | dtil-20260112.htm |
| 2025-12-30 | S-3 | precisionbiosiences-sx3.htm |
| 2025-11-10 | 8-K | dtil-20251110.htm |
| 2025-11-03 | 10-Q | dtil-20250930.htm |
| 2025-09-02 | 8-K | dtil-20250826.htm |
| 2025-08-07 | 10-Q | dtil-20250630.htm |
| 2025-08-06 | 8-K | dtil-20250806.htm |
| 2025-06-03 | 8-K | dtil-20250528.htm |
| Ms. Cindy Atwell |
| Chief Development & Business Officer |
| Ms. Juli Blanche | Chief People Officer |